Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

A new layer of degradation mechanism for PR-Set7/Set8 during cell cycle.

Zheng N, Dai X, Wang Z, Wei W.

Cell Cycle. 2016 Nov 16;15(22):3042-3047. Epub 2016 Sep 20.

PMID:
27649746
2.

Recent advances in SCF ubiquitin ligase complex: Clinical implications.

Zheng N, Zhou Q, Wang Z, Wei W.

Biochim Biophys Acta. 2016 Aug;1866(1):12-22. doi: 10.1016/j.bbcan.2016.05.001. Epub 2016 May 5. Review.

PMID:
27156687
3.

Epigenetic regulation of IL-12-dependent T cell proliferation.

Schaller M, Ito T, Allen RM, Kroetz D, Kittan N, Ptaschinski C, Cavassani K, Carson WF 4th, Godessart N, Grembecka J, Cierpicki T, Dou Y, Kunkel SL.

J Leukoc Biol. 2015 Oct;98(4):601-13. doi: 10.1189/jlb.1A0814-375RR. Epub 2015 Jun 9.

4.

The role of aberrant proteolysis in lymphomagenesis.

Sahasrabuddhe AA, Elenitoba-Johnson KS.

Curr Opin Hematol. 2015 Jul;22(4):369-78. doi: 10.1097/MOH.0000000000000156. Review.

5.

Hijacked in cancer: the KMT2 (MLL) family of methyltransferases.

Rao RC, Dou Y.

Nat Rev Cancer. 2015 Jun;15(6):334-46. doi: 10.1038/nrc3929. Review.

6.

SKP2 inactivation suppresses prostate tumorigenesis by mediating JARID1B ubiquitination.

Lu W, Liu S, Li B, Xie Y, Adhiambo C, Yang Q, Ballard BR, Nakayama KI, Matusik RJ, Chen Z.

Oncotarget. 2015 Jan 20;6(2):771-88.

7.

A SET-domain-independent role of WRAD complex in cell-cycle regulatory function of mixed lineage leukemia.

Ali A, Veeranki SN, Tyagi S.

Nucleic Acids Res. 2014 Jul;42(12):7611-24. doi: 10.1093/nar/gku458. Epub 2014 May 31.

8.

Identification of mixed lineage leukemia 1(MLL1) protein as a coactivator of heat shock factor 1(HSF1) protein in response to heat shock protein 90 (HSP90) inhibition.

Chen Y, Chen J, Yu J, Yang G, Temple E, Harbinski F, Gao H, Wilson C, Pagliarini R, Zhou W.

J Biol Chem. 2014 Jul 4;289(27):18914-27. doi: 10.1074/jbc.M114.574053. Epub 2014 May 15.

9.

Proteasome inhibitors evoke latent tumor suppression programs in pro-B MLL leukemias through MLL-AF4.

Liu H, Westergard TD, Cashen A, Piwnica-Worms DR, Kunkle L, Vij R, Pham CG, DiPersio J, Cheng EH, Hsieh JJ.

Cancer Cell. 2014 Apr 14;25(4):530-42. doi: 10.1016/j.ccr.2014.03.008.

10.

Harnessing the hidden antitumor power of the MLL-AF4 oncogene to fight leukemia.

Matkar S, Katona BW, Hua X.

Cancer Cell. 2014 Apr 14;25(4):411-3. doi: 10.1016/j.ccr.2014.03.028.

11.

Novel primate miRNAs coevolved with ancient target genes in germinal zone-specific expression patterns.

Arcila ML, Betizeau M, Cambronne XA, Guzman E, Doerflinger N, Bouhallier F, Zhou H, Wu B, Rani N, Bassett DS, Borello U, Huissoud C, Goodman RH, Dehay C, Kosik KS.

Neuron. 2014 Mar 19;81(6):1255-62. doi: 10.1016/j.neuron.2014.01.017. Epub 2014 Feb 27.

12.

Mechanisms of mixed-lineage leukemia.

Muntean AG.

Int J Hematol Oncol. 2013 Jun 1;2(3):207-217.

13.

The human oncoprotein MDM2 induces replication stress eliciting early intra-S-phase checkpoint response and inhibition of DNA replication origin firing.

Frum RA, Singh S, Vaughan C, Mukhopadhyay ND, Grossman SR, Windle B, Deb S, Deb SP.

Nucleic Acids Res. 2014 Jan;42(2):926-40. doi: 10.1093/nar/gkt944. Epub 2013 Oct 24.

14.

The G2/M regulator histone demethylase PHF8 is targeted for degradation by the anaphase-promoting complex containing CDC20.

Lim HJ, Dimova NV, Tan MK, Sigoillot FD, King RW, Shi Y.

Mol Cell Biol. 2013 Nov;33(21):4166-80. doi: 10.1128/MCB.00689-13. Epub 2013 Aug 26.

15.

Transcriptional response to stress in the dynamic chromatin environment of cycling and mitotic cells.

Vihervaara A, Sergelius C, Vasara J, Blom MA, Elsing AN, Roos-Mattjus P, Sistonen L.

Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):E3388-97. doi: 10.1073/pnas.1305275110. Epub 2013 Aug 19.

16.

HGF-MET signals via the MLL-ETS2 complex in hepatocellular carcinoma.

Takeda S, Liu H, Sasagawa S, Dong Y, Trainor PA, Cheng EH, Hsieh JJ.

J Clin Invest. 2013 Jul;123(7):3154-65. doi: 10.1172/JCI65566. Epub 2013 Jun 24.

17.

Flipping the switch from g1 to s phase with e3 ubiquitin ligases.

Rizzardi LF, Cook JG.

Genes Cancer. 2012 Nov;3(11-12):634-48. doi: 10.1177/1947601912473307.

18.

Histone lysine methylation dynamics: establishment, regulation, and biological impact.

Black JC, Van Rechem C, Whetstine JR.

Mol Cell. 2012 Nov 30;48(4):491-507. doi: 10.1016/j.molcel.2012.11.006. Review.

19.

A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity.

Wang J, Muntean AG, Wu L, Hess JL.

J Biol Chem. 2012 Dec 21;287(52):43410-6. doi: 10.1074/jbc.M112.423855. Epub 2012 Nov 5.

20.

Cell cycle control in acute myeloid leukemia.

Schnerch D, Yalcintepe J, Schmidts A, Becker H, Follo M, Engelhardt M, Wäsch R.

Am J Cancer Res. 2012;2(5):508-28. Epub 2012 Aug 20.

Supplemental Content

Support Center